Table of Contents Table of Contents
Previous Page  299 / 398 Next Page
Information
Show Menu
Previous Page 299 / 398 Next Page
Page Background

294

Malignant melanoma occurred in maxillary sinus: case

report with review of literature

S.H. Shin

∗

, S.G. Kim

Department of Oral and Maxillofacial Surgery, College of

Dentistry, Gangneung-Wonju National University, Gangneung,

Republic of Korea

Background:

Malignant melanoma occurred in sinonasal mucosa

is rare malignancy. It accounts for less than 1% of all malignant

melanoma. In most of cases, it occurs primarily in mucosa of

nasal cavity. However, in some rare cases, paranasal sinus can be

primary place of malignant melanoma.

Objectives:

The purpose of this report is to introduce a case of a

patient who had malignant melanoma which occurred primarily

on maxillary sinus.

Methods:

The patient with malignant melanoma on maxillary

sinus visited our clinic. Considering age and personal circum-

stances of patient, we removed tumour without safety margin

and fat pad graft was done for covering bony defect. After

stitch-out, the patient was referred to haemato-oncology for addi-

tional radiation therapy or chemotherapy. For review of literature,

PubMed was searched with keywords of maxillary sinus and

malignant melanoma. On the result, the literatures about malignant

melanoma occurred in nasal cavity primarily were excluded.

Findings and Conclusion:

Malignant melanoma occurred in

maxillary sinus showed aetiologic, histological features and sur-

vival rate that are quite different with skin malignant melanoma.

http://dx.doi.org/10.1016/j.ijom.2017.02.989

Perioperative management of head and neck cancer patients

among United States of America maxillofacial units

M. Siew

∗

, S. Chandra

University of Washington, Seattle, United States

Background:

Oncologic and microvascular reconstruction in

oral/maxillofacial surgery has broadened treatment options and

improved aesthetic and functional outcomes. However, evidence-

based guidelines for perioperative management of head-and-neck

cancer patients are meagre. By delineating contemporary surgical

practices, we hope to facilitate consensus among head-and-neck

specialists on evidence-based treatments that improve outcomes

and reduce length-of-stay and hospital expenses.

Objectives:

To assess variation among United States of America

(USA) maxillofacial units concerning perioperative management

of head-and-neck cancer patients, determine whether current prac-

tices conform to published evidence in literature, and present an

evidence-based clinical care pathway.

Methods:

Maxillofacial units performing oncologic and

microvascular reconstructive surgery in the USA were surveyed

with nominal/ordinal multiple-choice, matrix, and free response

questions. Descriptive analysis was performed.

Findings:

30% response rate is comparable to published studies.

66.1% often/always submit biopsy specimens for second review.

81.1% have no preference regarding order of imaging/biopsy.

Intraoperatively, 47.9% often/always avoid vasopressors, and

25% always use aspirin intraoperatively while 41.7% never do.

72.4% rarely/never place implants intraoperatively. Postopera-

tively, 77.1% often/always provide intensive care unit care and

60.4% position at neutral and/or 30 degrees elevated. 64.6%

often/always perform elective tracheostomies. In addition to clin-

ical observation, adjunctive flap monitoring primarily involves

surface and invasive Doppler.

Conclusion:

Our survey is the only large-scale study of care prac-

tices among USA maxillofacial units performing head-and-neck

oncologic surgery and demonstrates areas of agreement and non-

uniformity. More prospective clinical trials are needed to identify

evidence-based clinical practices that improve care and decrease

healthcare costs. A clinical care pathway designed by the senior

author for head-and-neck cancer patients will be presented.

http://dx.doi.org/10.1016/j.ijom.2017.02.990

Circulating microparticles levels in the patients of lymphatic

malformations: possible role in the development of lymphatic

malformations

Y. Sun

∗

, J. Ren, B. Liu, Y. Zhao

Hospital of Stomatology, Wuhan University, Wuhan, China

Background:

Microparticles (MPs) are circulating membrane

particles of less than a micrometre in diameter shed from endothe-

lial and blood cells. Recent literature suggests that MPs may

possess biological functions and mediate the communication

between vascular cells. We hypothesised that MPs may have pos-

sible role in the development of lymphatic malformations.

Objectives:

To study the clinical significance of circulating

microparticles levels of the local lesion and peripheral blood in

the patients of lymphatic malformations.

Methods:

Collecting and separating the circulatingmicroparticles

of the local lesion and peripheral blood in the patients of lym-

phatic malformations and the normals. Flow cytometry was used

to test the concentration and the classification of the circulating

microparticles. According to the results combined with clinical

indicators to analyse the clinical significance.

Findings:

Compared with the normals, the total circulating

microparticles levels of peripheral blood in the patients of lym-

phatic malformations were significantly increased. The circulating

microparticles levels of cystic fluid in the local lesions were higher

than those of the peripheral blood in the patients of lymphatic

malformations and the normals, and the classification was also

different. In addition, the circulating microparticles levels of cys-

tic fluid in the local lesions and peripheral blood were significantly

higher in the larger lesions.

Conclusion:

The levels and the classification of the circulating

microparticles in the patients of lymphatic malformations were

different with those in the normals. The circulating microparticles

may contribute to the development of lymphatic malformations.

http://dx.doi.org/10.1016/j.ijom.2017.02.991